Annexin A5 is involved in apoptosis and downregulation of the phosphatidylinositol 3-kinase (PI3K)/Akt/NF-kB signalling pathway in certain tumours [96] and has been demonstrated to inhibit cPLA2 in peripheral blood lymphocyte cell lines [97]. The gene discussed is AKT1; the disease is neoplasm.